Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome

Antónia Szántó, M. Harangi, I. Seres, G. Paragh, M. Zeher

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: The aim of the study was to examine human serum paraoxonase 1 (PON1) activity, phenotype distribution and lipid parameters in patients with Sjögren's syndrome. The prevalence of cardio-and cerebrovascular diseases in SS patients was also evaluated after a 5-year follow-up. Methods. Fifty-seven SS patients and 17 age-matched healthy controls were enrolled into the study. PON1 and arylesterase activities were measured spectrophotometrically. The phenotype distribution of PON1 was determined by the dual-substrate method. Results. Significantly lower PON1 activity was found in patients with SS compared with the control group (98.00 6 69.21 versus 203.3 6 92.78 U ml-1; P <0.001). There were significant differences in PON1 phenotype distribution of SS patients and controls (AA/AB/BB: 91.2/8.8/0 versus 58.8/29.4/11.8%; P <0.01). No significant correlations were found between PON activity and disease-characteristic autoantibodies, including anti-Ro/SS-A and anti-La/SS-B concentrations. PON activity did not predict the cerebro/cardiovascular risk in SS patients during the 5-year follow-up. Conclusions: Despite the relatively small sample size that reduces the power of the study, decreased PON activity may be a possible cardiovascular risk factor in SS. Disadvantageous PON1 phenotype distribution may contribute to the decreased PON activity in these patients.

Original languageEnglish
Pages (from-to)605-609
Number of pages5
JournalInternational Immunology
Volume22
Issue number7
DOIs
Publication statusPublished - May 24 2010

Fingerprint

Aryldialkylphosphatase
Phenotype
Cerebrovascular Disorders
human PON1 protein
Autoantibodies
Sample Size
Lipids
Control Groups
Serum

Keywords

  • Autoimmunity
  • Cardiovascular risk
  • Paraoxonase phenotype

ASJC Scopus subject areas

  • Immunology

Cite this

Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome. / Szántó, Antónia; Harangi, M.; Seres, I.; Paragh, G.; Zeher, M.

In: International Immunology, Vol. 22, No. 7, 24.05.2010, p. 605-609.

Research output: Contribution to journalArticle

@article{ff0d9f2b821d4314b2616c5115088608,
title = "Decreased human paraoxonase-1 activity in patients with Sj{\"o}gren's syndrome",
abstract = "Objectives: The aim of the study was to examine human serum paraoxonase 1 (PON1) activity, phenotype distribution and lipid parameters in patients with Sj{\"o}gren's syndrome. The prevalence of cardio-and cerebrovascular diseases in SS patients was also evaluated after a 5-year follow-up. Methods. Fifty-seven SS patients and 17 age-matched healthy controls were enrolled into the study. PON1 and arylesterase activities were measured spectrophotometrically. The phenotype distribution of PON1 was determined by the dual-substrate method. Results. Significantly lower PON1 activity was found in patients with SS compared with the control group (98.00 6 69.21 versus 203.3 6 92.78 U ml-1; P <0.001). There were significant differences in PON1 phenotype distribution of SS patients and controls (AA/AB/BB: 91.2/8.8/0 versus 58.8/29.4/11.8{\%}; P <0.01). No significant correlations were found between PON activity and disease-characteristic autoantibodies, including anti-Ro/SS-A and anti-La/SS-B concentrations. PON activity did not predict the cerebro/cardiovascular risk in SS patients during the 5-year follow-up. Conclusions: Despite the relatively small sample size that reduces the power of the study, decreased PON activity may be a possible cardiovascular risk factor in SS. Disadvantageous PON1 phenotype distribution may contribute to the decreased PON activity in these patients.",
keywords = "Autoimmunity, Cardiovascular risk, Paraoxonase phenotype",
author = "Ant{\'o}nia Sz{\'a}nt{\'o} and M. Harangi and I. Seres and G. Paragh and M. Zeher",
year = "2010",
month = "5",
day = "24",
doi = "10.1093/intimm/dxq045",
language = "English",
volume = "22",
pages = "605--609",
journal = "International Immunology",
issn = "0953-8178",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome

AU - Szántó, Antónia

AU - Harangi, M.

AU - Seres, I.

AU - Paragh, G.

AU - Zeher, M.

PY - 2010/5/24

Y1 - 2010/5/24

N2 - Objectives: The aim of the study was to examine human serum paraoxonase 1 (PON1) activity, phenotype distribution and lipid parameters in patients with Sjögren's syndrome. The prevalence of cardio-and cerebrovascular diseases in SS patients was also evaluated after a 5-year follow-up. Methods. Fifty-seven SS patients and 17 age-matched healthy controls were enrolled into the study. PON1 and arylesterase activities were measured spectrophotometrically. The phenotype distribution of PON1 was determined by the dual-substrate method. Results. Significantly lower PON1 activity was found in patients with SS compared with the control group (98.00 6 69.21 versus 203.3 6 92.78 U ml-1; P <0.001). There were significant differences in PON1 phenotype distribution of SS patients and controls (AA/AB/BB: 91.2/8.8/0 versus 58.8/29.4/11.8%; P <0.01). No significant correlations were found between PON activity and disease-characteristic autoantibodies, including anti-Ro/SS-A and anti-La/SS-B concentrations. PON activity did not predict the cerebro/cardiovascular risk in SS patients during the 5-year follow-up. Conclusions: Despite the relatively small sample size that reduces the power of the study, decreased PON activity may be a possible cardiovascular risk factor in SS. Disadvantageous PON1 phenotype distribution may contribute to the decreased PON activity in these patients.

AB - Objectives: The aim of the study was to examine human serum paraoxonase 1 (PON1) activity, phenotype distribution and lipid parameters in patients with Sjögren's syndrome. The prevalence of cardio-and cerebrovascular diseases in SS patients was also evaluated after a 5-year follow-up. Methods. Fifty-seven SS patients and 17 age-matched healthy controls were enrolled into the study. PON1 and arylesterase activities were measured spectrophotometrically. The phenotype distribution of PON1 was determined by the dual-substrate method. Results. Significantly lower PON1 activity was found in patients with SS compared with the control group (98.00 6 69.21 versus 203.3 6 92.78 U ml-1; P <0.001). There were significant differences in PON1 phenotype distribution of SS patients and controls (AA/AB/BB: 91.2/8.8/0 versus 58.8/29.4/11.8%; P <0.01). No significant correlations were found between PON activity and disease-characteristic autoantibodies, including anti-Ro/SS-A and anti-La/SS-B concentrations. PON activity did not predict the cerebro/cardiovascular risk in SS patients during the 5-year follow-up. Conclusions: Despite the relatively small sample size that reduces the power of the study, decreased PON activity may be a possible cardiovascular risk factor in SS. Disadvantageous PON1 phenotype distribution may contribute to the decreased PON activity in these patients.

KW - Autoimmunity

KW - Cardiovascular risk

KW - Paraoxonase phenotype

UR - http://www.scopus.com/inward/record.url?scp=77954291930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954291930&partnerID=8YFLogxK

U2 - 10.1093/intimm/dxq045

DO - 10.1093/intimm/dxq045

M3 - Article

C2 - 20497955

AN - SCOPUS:77954291930

VL - 22

SP - 605

EP - 609

JO - International Immunology

JF - International Immunology

SN - 0953-8178

IS - 7

ER -